Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
|
10/07 | Jazz Pharmaceuticals plc asciende a Samantha Pearce a Directora Comercial | CI |
20/06 | JAZZ PHARMACEUTICALS PLC : Needham & Co. mantiene su recomendación de compra | ZM |
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 3 659 | 100,0 % | 3 834 | 100,0 % | +4,78 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
91,0
%
| 3 370 | 92,1 % | 3 490 | 91,0 % | +3,55 % |
Europe
7,0
%
| 240 | 6,5 % | 269 | 7,0 % | +12,35 % |
All Other
2,0
%
| 49 | 1,3 % | 75 | 2,0 % | +51,92 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01/03/03 |
Renée Galá
PSD | President | 52 | 16/03/20 |
Robert Iannone
CTO | Chief Tech/Sci/R&D Officer | 57 | 29/05/19 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18/01/12 |
Andrea N. Flynn
IRC | Investor Relations Contact | - | - |
Shawn Mindus
PRN | Corporate Officer/Principal | - | - |
John Miller
PRN | Corporate Officer/Principal | - | - |
Heidi Manna
HRO | Human Resources Officer | 53 | 01/11/18 |
Neena Patil
LAW | General Counsel | 49 | 01/07/19 |
Aislinn Doody
SEC | Corporate Secretary | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01/03/03 |
Norbert Riedel
BRD | Director/Board Member | 66 | 13/05/13 |
Patrick Enright
BRD | Director/Board Member | 62 | 01/01/09 |
Peter Gray
BRD | Director/Board Member | 69 | 08/05/13 |
Ken O'Keefe
BRD | Director/Board Member | 57 | 01/01/04 |
Rick Winningham
BRD | Director/Board Member | 64 | 01/01/10 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18/01/12 |
Heather McSharry
BRD | Director/Board Member | 62 | 02/05/13 |
Catherine Sohn
BRD | Director/Board Member | 71 | 27/07/12 |
Anne O’Riordan
BRD | Director/Board Member | 56 | 14/02/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 63 062 356 | 61 308 189 ( 97,22 %) | 0 | 97,22 % |
Información de la empresa
Jazz Pharmaceuticals Plc
Waterloo Exchange Waterloo Road
4, Dublin
+353 1 634 7800
http://www.jazzpharmaceuticals.com![Dirección Jazz Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/52352.png)
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Jazz Securities DAC
|
Finance/Rental/Leasing
|
Jazz Investments II Ltd.
|
Finance/Rental/Leasing
|
Jazz Financing Holdings Ltd.
![]() Jazz Financing Holdings Ltd. MiscellaneousMiscellaneous Part of Jazz Pharmaceuticals Plc, Jazz Financing Holdings Ltd. is an investment holding Irish company. The company is located in Ireland. |
Miscellaneous
|
Jazz Investments Europe Ltd.
| |
Jazz Pharmaceuticals Ireland Ltd.
![]() Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Ireland Ltd. is an Irish biopharmaceutical company that focuses on the identification, development, and commercialization of pharmaceutical products. The company is based in Dublin, Ireland. The company was founded by Bruce C. Cozadd, who has been the CEO since incorporation. |
Pharmaceuticals: Major
|
Jazz Financing I DAC
|
Finance/Rental/Leasing
|
Jazz Pharmaceuticals Ireland Holdings Ltd.
| |
Jazz Financing Lux SARL
![]() Jazz Financing Lux SARL Finance/Rental/LeasingFinance Part of Jazz Pharmaceuticals Plc, Jazz Financing Lux SARL provides financing services. The company is based in Luxembourg, Luxembourg. Founded in 2013. |
Finance/Rental/Leasing
|
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+61,53 % | 856 mil M | |
+38,95 % | 631 mil M | |
-3,66 % | 359 mil M | |
+15,06 % | 325 mil M | |
+9,18 % | 297 mil M | |
+5,89 % | 234 mil M | |
+16,53 % | 226 mil M | |
+15,67 % | 177 mil M | |
+2,47 % | 165 mil M |
- Bolsa de valores
- Acciones
- Acción JAZZ
- Acción
- Empresa Jazz Pharmaceuticals, Inc.